Experience with a higher impedance, fixed helix, steroid-eluting pacing lead. The SWEET PICOTIP Rx Study Group

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Medical Devices

Background:

• Pacemaker leads are crucial for delivering electrical impulses to the heart.
• Steroid-eluting leads aim to reduce inflammation and improve lead performance.
• Optimizing lead impedance and pacing thresholds is essential for efficient pacemaker function.

Purpose of the Study:

• To evaluate the electrical characteristics of a novel steroid-eluting pacing lead.
• To compare the performance of the study lead against historical control data.
• To assess the impact of the lead's design on pacing system energy requirements.

Main Methods:

• A multicenter trial involving the implantation of 132 pacing leads in 61 patients.
• Comparison of electrical parameters (pacing threshold, impedance, sensing) with historical control data.
• Analysis of lead performance at the 3-month follow-up point.

Main Results:

• The study lead exhibited significantly lower pacing thresholds in both the atrium (0.72 vs. 1.29) and ventricle (0.71 vs. 1.52) (P < 0.01).
• Significantly higher impedance values were recorded for the study lead in the atrium (923 vs. 719) and ventricle (980 vs. 664) (P < 0.01).
• Cardiac sensing capabilities were comparable between the study lead and historical controls.

Conclusions:

• The steroid-eluting pacing lead demonstrates superior electrical properties, including lower pacing thresholds and higher impedance.
• These characteristics suggest a potential for reduced energy consumption in pacemaker systems.
• The findings support the clinical utility of this advanced pacing lead technology.